<p><img src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/04/Tilray-Brands.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/04/Tilray-Brands.png"/></p>
<p>Tilray Brands 的股價在今年持續下跌，目前交易價格已降至去年 7 月以來的最低水平。它最近失去了關鍵支撐位 5.95 美元，較去年 10 月的最高點下跌超過 76%。那麼，現在買入是否安全呢？</p>
<h2>Tilray Brands 股票因風險上升而暴跌</h2>
<p>TLRY 股票本週暴跌，目前已降至去年 7 月以來的最低水平。這一下降在司法部宣佈將重新安排大麻的消息後加速。此前，特朗普總統在 1 月發佈了一項行政命令。</p>
<p>美國緝毒局（DEA）將於今年 6 月 29 日就這些變更舉行首次聽證會。如果這一過程順利完成，將會顯著改變行業，使公司運營變得更加容易。</p>
<p>然而，該過程仍面臨一些重大風險，包括訴訟，例如 “智能大麻方法”（SAM）組織。該禁毒組織認為，放寬限制違反了聯邦法律，並且會對公共健康造成危害。</p>
<p>因此，正在進行的法律行動可能會在長期內延遲重新安排的過程。例如，喬·拜登試圖改變分類的努力面臨重大延遲，他在完成之前就已卸任總統。</p>
<p>成功的重新安排將對這個面臨多重聯邦障礙的 500 億美元行業是個好消息。FDA 批准的大麻產品將被移至低至中等濫用潛力的類別。</p>
<p>Tilray Brands 銷售多種產品，如 Mollo、Good Supply 和 Redecan，在美國並沒有主要市場。它在包括加拿大和德國在內的 20 多個國家銷售其產品。</p>
<p>管理層一直指出美國的監管挑戰，在美國，大麻被歸類為受控物質產品。它指出一旦監管環境改變，可能會進入美國市場。該公司最近表示：</p>
<p>“Tilray 準備與監管機構和醫療保健提供者合作，負責任地擴大醫療大麻的獲取，並幫助塑造美國這一行業的未來。”</p>
<h2>飲料業務仍在掙扎</h2>
<p>Tilray Brands 通過收購不斷擴大其業務。具體來説，它花費數百萬美元從 AB InBev 和 Molson Coors 等公司購買飲料品牌。其目標是成為酒精業務的主要參與者。</p>
<p>然而，全球啤酒消費下降的跡象表明，該業務仍在掙扎。例如，最近的財務結果顯示，其飲料收入在第三季度降至 4260 萬美元，而去年同期的收入超過 5590 萬美元。此外，毛利率持續下降，降至 32%。</p>
<p>由於全球啤酒消費增長停滯，該部門可能仍將面臨壓力。數據顯示，全球啤酒市場目前為 9860 億美元，預計在未來幾年將逐漸增長，到 2032 年達到 1.3 萬億美元。</p>
<h2>Tilray Brands 股價技術分析</h2>
<p><img src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/05/Tilray-stock-1.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/05/Tilray-stock-1.png"/></p>
<p><em>TLRY 股票圖表 | 來源：</em> <em>TradingView</em></p>
<p>日線圖顯示，TLRY 股價在過去幾個月中暴跌。從 4 月的 9.30 美元降至今天的 5.41 美元，創下數月來的最低水平。</p>
<p>該股票最近跌破了關鍵支撐位 5.98 美元，這是今年 3 月的最低水平。跌破該水平確認了看跌前景。</p>
<p>不過，該股票尚未超賣，相對強弱指數（RSI）交易在 33，為 3 月 31 日以來的最低水平。因此，TLRY 股價在短期內可能還有進一步下跌的空間，可能會低於 5 美元。</p>
<p>本文首次出現在 Invezz 上，標題為 “Tilray Brands 股票正在自由下跌：關鍵原因及接下來會發生什麼”</p>

TLRY

<p>Tilray Brands 的股票正在經歷顯著下跌，目前交易價格為去年七月以來的最低點，比十月的峯值下跌超過 76%。在司法部宣佈重新安排大麻的消息後，股價下跌加速，該政策面臨法律挑戰。儘管重新安排可能帶來潛在好處，但 Tilray 的飲料部門正面臨收入下降的困境。股票的技術分析顯示進一步下行的潛力，價格最近跌破了關鍵支撐位</p>

<p><img src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/04/Tilray-Brands.png" alt="" original-src="https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/04/Tilray-Brands.png"/></p>
<p>Tilray Brands stock price remains in a freefall this year and is now trading at its lowest level since July 9 last year. It recently lost the crucial support level at $5.95, and is down by over 76% from its highest point in October last year. So, is it safe to buy the dip?</p>
<div class="lb-trans"><p>Tilray Brands 的股價在今年持續下跌，目前交易價格已降至去年 7 月以來的最低水平。它最近失去了關鍵支撐位 5.95 美元，較去年 10 月的最高點下跌超過 76%。那麼，現在買入是否安全呢？</p>
</div><h2>Tilray Brands stock has crashed amid rising risks</h2>
<div class="lb-trans"><h2>Tilray Brands 股票因風險上升而暴跌</h2>
</div><p>TLRY stock has plunged this week and is now at its lowest level since July last year. This retreat accelerated after the Justice Department announced that it would reschedule cannabis. This followed an executive order by President Donald Trump in January.</p>
<div class="lb-trans"><p>TLRY 股票本週暴跌，目前已降至去年 7 月以來的最低水平。這一下降在司法部宣佈將重新安排大麻的消息後加速。此前，特朗普總統在 1 月發佈了一項行政命令。</p>
</div><p>The DEA will hold its first hearing on these changes on June 29 this year regarding the rescheduling. If the process concludes and is successful, it will dramatically change the industry by making it easier for companies to operate.</p>
<div class="lb-trans"><p>美國緝毒局（DEA）將於今年 6 月 29 日就這些變更舉行首次聽證會。如果這一過程順利完成，將會顯著改變行業，使公司運營變得更加容易。</p>
</div><p>However, the process still faces some major risks, including lawsuits, including the Smart Approaches to Marijuana (SAM). The group of prohibitionists argued that loosening restrictions violates federal law. It also argues that it will be harmful to public health.</p>
<div class="lb-trans"><p>然而，該過程仍面臨一些重大風險，包括訴訟，例如 “智能大麻方法”（SAM）組織。該禁毒組織認為，放寬限制違反了聯邦法律，並且會對公共健康造成危害。</p>
</div><p>Therefore, there is a likelihood that the ongoing legal actions will delay the rescheduling process in the long-term. For example, Joe Biden’s attempts to change the classification faced substantial delays and he exited the presidency before it was completed.</p>
<div class="lb-trans"><p>因此，正在進行的法律行動可能會在長期內延遲重新安排的過程。例如，喬·拜登試圖改變分類的努力面臨重大延遲，他在完成之前就已卸任總統。</p>
</div><p>A successful rescheduling will be a good thing for the $50 billion industry that has faced multiple barriers at the federal level. Marijuana products approved by the FDA will be moved to a category with low to moderate potential abuse.</p>
<div class="lb-trans"><p>成功的重新安排將對這個面臨多重聯邦障礙的 500 億美元行業是個好消息。FDA 批准的大麻產品將被移至低至中等濫用潛力的類別。</p>
</div><p>Tilray Brands, which sells several products like Mollo, Good Supply, and Redecan, does not have a major presence in the United States. It instead sells its products in over 20 countries, including in Canada and Germany.</p>
<div class="lb-trans"><p>Tilray Brands 銷售多種產品，如 Mollo、Good Supply 和 Redecan，在美國並沒有主要市場。它在包括加拿大和德國在內的 20 多個國家銷售其產品。</p>
</div><p>The management has always pointed to the regulatory challenges in the US, where cannabis has been classified as a controlled substance product. It has pointed to a potential entry to the US once the regulatory environment changes. The company recently said:</p>
<div class="lb-trans"><p>管理層一直指出美國的監管挑戰，在美國，大麻被歸類為受控物質產品。它指出一旦監管環境改變，可能會進入美國市場。該公司最近表示：</p>
</div><p>“Tilray stands ready to partner with regulators and healthcare providers to responsibly expand access to medical cannabis and help shape the future of this industry in the United States.”</p>
<div class="lb-trans"><p>“Tilray 準備與監管機構和醫療保健提供者合作，負責任地擴大醫療大麻的獲取，並幫助塑造美國這一行業的未來。”</p>
</div><h2>Beverage business is still struggling</h2>
<div class="lb-trans"><h2>飲料業務仍在掙扎</h2>
</div><p>Tilray Brands has been growing its business through acquisitions. Precisely, it has spent millions of dollars buying beverage brands from companies like AB InBev and Molson Coors. Its goal is to become a major player in the alcohol business.</p>
<div class="lb-trans"><p>Tilray Brands 通過收購不斷擴大其業務。具體來説，它花費數百萬美元從 AB InBev 和 Molson Coors 等公司購買飲料品牌。其目標是成為酒精業務的主要參與者。</p>
</div><p>However, there are signs that the business is still struggling as beer consumption drops globally. For example, the most recent financial results revealed that its beverage revenue dropped to $42.6 million in the third quarter. It had made over $55.9 million in revenue in the same period a year earlier. Also the gross margin continued falling, reaching 32%.</p>
<div class="lb-trans"><p>然而，全球啤酒消費下降的跡象表明，該業務仍在掙扎。例如，最近的財務結果顯示，其飲料收入在第三季度降至 4260 萬美元，而去年同期的收入超過 5590 萬美元。此外，毛利率持續下降，降至 32%。</p>
</div><p>The division will likely remain under pressure as global beer consumption growth stalls. Data shows that the global beer market stood at $986 billion today, and is expected to grow gradually in the coming years to hit $1.3 trillion by 2032.</p>
<div class="lb-trans"><p>由於全球啤酒消費增長停滯，該部門可能仍將面臨壓力。數據顯示，全球啤酒市場目前為 9860 億美元，預計在未來幾年將逐漸增長，到 2032 年達到 1.3 萬億美元。</p>
</div><h2>Tilray Brands stock price technical analysis</h2>
<div class="lb-trans"><h2>Tilray Brands 股價技術分析</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/05/Tilray-stock-1.png" alt="" original-src="https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/05/Tilray-stock-1.png"/></p>
<p><em>TLRY stock chart | Source:</em> <em>TradingView</em></p>
<div class="lb-trans"><p><em>TLRY 股票圖表 | 來源：</em> <em>TradingView</em></p>
</div><p>The daily chart reveals that the TLRY stock price has crashed in the past few months. It has dropped from $9.30 in April to $5.41 today, its lowest level in months.</p>
<div class="lb-trans"><p>日線圖顯示，TLRY 股價在過去幾個月中暴跌。從 4 月的 9.30 美元降至今天的 5.41 美元，創下數月來的最低水平。</p>
</div><p>The stock recently plunged below the key support level at $5.98, its lowest level in March this year. Moving below that level confirmed the bearish outlook.</p>
<div class="lb-trans"><p>該股票最近跌破了關鍵支撐位 5.98 美元，這是今年 3 月的最低水平。跌破該水平確認了看跌前景。</p>
</div><p>Still, the stock is not yet oversold, with the Relative Strength Index (RSI) trading at 33, its lowest level since March 31st. Therefore, the TLRY share price has more downside to go in the near term, potentially below $5.</p>
<div class="lb-trans"><p>不過，該股票尚未超賣，相對強弱指數（RSI）交易在 33，為 3 月 31 日以來的最低水平。因此，TLRY 股價在短期內可能還有進一步下跌的空間，可能會低於 5 美元。</p>
</div><p>The post Tilray Brands stock is in a freefall: key reasons and what next appeared first on Invezz</p>
<div class="lb-trans"><p>本文首次出現在 Invezz 上，標題為 “Tilray Brands 股票正在自由下跌：關鍵原因及接下來會發生什麼”</p>
</div>

Tilray Brands 的股票正在急劇下跌：關鍵原因及未來走勢